Bruce Badner

Analyst-Equity at

American Century Investment Management, Inc.

Finance

Health Technology

Consumer Services

Profile

Bruce Badner is currently a Senior Investment Analyst at American Century Investment Management, Inc., a position held since 2014.
Former positions include Director at Elan Pharmaceuticals LLC in 2010, Analyst at Goldman Sachs & Co. LLC in 1997, Analyst at Sanford C.
Bernstein & Co. LLC from 2011 to 2014, and Principal at Pfizer Venture Investments LLC in 2005.
Education includes an undergraduate degree (1994) and a graduate degree (1995) from The Trustees of Columbia University in The City of New York, and an MBA from the Massachusetts Institute of Technology (2000).

Bruce Badner active positions

Companies	Position	Start
American Century Investment Management, Inc. American Century Investment Management, Inc. Investment ManagersFinance ACIM uses a variety of methods of analysis and investment strategies in managing their clients’ assets. These methods of analysis and strategies are generally designed for strategic, long-term investing. Most client portfolios managed by the firm pursue an investment strategy using an equity, fixed income, alternative or multi-asset approach.	Analyst-Equity	01/01/2014

All active positions of Bruce Badner

Former positions of Bruce Badner

Companies	Position	End
Sanford C. Bernstein & Co. LLC Sanford C. Bernstein & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	01/01/2014
Elan Pharmaceuticals LLC Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Corporate Officer/Principal	31/12/2010
Pfizer Venture Investments LLC Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor.	Corporate Officer/Principal	31/12/2005
Goldman Sachs & Co. LLC Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Corporate Officer/Principal	31/12/1997

See the detail of Bruce Badner's experience

Training of Bruce Badner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bruce Badner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
American Century Investment Management, Inc. American Century Investment Management, Inc. Investment ManagersFinance ACIM uses a variety of methods of analysis and investment strategies in managing their clients’ assets. These methods of analysis and strategies are generally designed for strategic, long-term investing. Most client portfolios managed by the firm pursue an investment strategy using an equity, fixed income, alternative or multi-asset approach.	Finance
Elan Pharmaceuticals LLC Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Goldman Sachs & Co. LLC Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Sanford C. Bernstein & Co. LLC Sanford C. Bernstein & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
Pfizer Venture Investments LLC Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor.	Finance